Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Neoantigen Cancer Vaccine”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Study completedNCT06614140
What this trial is testing

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Who this might be right for
CancerSolid Tumor, Adult
Seqker Biosciences, Inc. 8
Not applicableUnknownNCT05192460
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer

Who this might be right for
Gastric CancerEsophageal CancerLiver Cancer
jianming xu 30
Not applicableUnknownNCT05359354
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors

Who this might be right for
Solid Tumor
YueJuan Cheng 36
Not applicableUnknownNCT04145232
What this trial is testing

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Who this might be right for
Non Small Cell Lung CancerNeoepitopesNeoantigens+3 more
Ardigen 30
Very early researchEnrolling By InvitationNCT07316361
What this trial is testing

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial Carcinoma Stage III
Biogenea Pharmaceuticals Ltd. 40
Early research (Phase 1)UnknownNCT05235607
What this trial is testing

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Who this might be right for
CarcinomaMelanomaBladder Cancer+1 more
Sichuan University 60
Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Early research (Phase 1)UnknownNCT02956551
What this trial is testing

Personalized DC Vaccine for Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sichuan University 20
Early research (Phase 1)Active Not RecruitingNCT02950766
What this trial is testing

NeoVax Plus Ipilimumab in Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
Patrick Ott, MD, PhD 19
Not applicableStudy completedNCT05158621
What this trial is testing

A Screening Study Targeting Tumor-specific Antigens

Who this might be right for
Metastatic Colorectal CancerStage II/III Colon Cancer
Gritstone bio, Inc. 22
Not applicableUnknownNCT05227378
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Shen Lin 36
Early research (Phase 1)UnknownNCT05767684
What this trial is testing

Neoantigen Derived DCs as Cancer Treatment

Who this might be right for
Refractory TumorSolid Tumor
National Health Research Institutes, Taiwan 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365280
What this trial is testing

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
ZSky Biotech Inc 78
Early research (Phase 1)Active Not RecruitingNCT02287428
What this trial is testing

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute 56
Not applicableLooking for participantsNCT06751966
What this trial is testing

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)Looking for participantsNCT07002203
What this trial is testing

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRecurrent Cancer+2 more
Seqker Biosciences, Inc. 10
Very early researchLooking for participantsNCT06980155
What this trial is testing

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine 60
Early research (Phase 1)Ended earlyNCT03422094
What this trial is testing

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 3
Testing effectiveness (Phase 2)Looking for participantsNCT06751901
What this trial is testing

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Not applicableAvailableNCT07612930
What this trial is testing

Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.
Load More Results